Strata Skin Sciences Debt to Equity Ratio 2010-2024 | SSKN

Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending December 31, 2024 was 3.06.
Strata Skin Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.03B $0.01B 6.27
2024-09-30 $0.03B $0.01B 3.30
2024-06-30 $0.03B $0.01B 3.17
2024-03-31 $0.03B $0.01B 3.25
2023-12-31 $0.03B $0.01B 2.31
2023-09-30 $0.03B $0.02B 1.91
2023-06-30 $0.04B $0.02B 2.27
2023-03-31 $0.03B $0.02B 1.54
2022-12-31 $0.03B $0.02B 1.39
2022-09-30 $0.03B $0.02B 1.44
2022-06-30 $0.03B $0.02B 1.40
2022-03-31 $0.03B $0.02B 1.32
2021-12-31 $0.02B $0.03B 0.83
2021-09-30 $0.02B $0.03B 0.79
2021-06-30 $0.02B $0.03B 0.74
2021-03-31 $0.02B $0.02B 0.90
2020-12-31 $0.02B $0.03B 0.81
2020-09-30 $0.02B $0.03B 0.82
2020-06-30 $0.02B $0.03B 0.73
2020-03-31 $0.02B $0.03B 0.64
2019-12-31 $0.02B $0.03B 0.65
2019-09-30 $0.02B $0.03B 0.65
2019-06-30 $0.02B $0.03B 0.63
2019-03-31 $0.02B $0.03B 0.58
2018-12-31 $0.02B $0.03B 0.52
2018-09-30 $0.01B $0.03B 0.38
2018-06-30 $0.01B $0.03B 0.37
2018-03-31 $0.02B $0.02B 0.86
2017-12-31 $0.02B $0.02B 0.97
2017-09-30 $0.02B $0.02B 0.67
2017-06-30 $0.03B $0.01B 2.69
2017-03-31 $0.03B $0.01B 2.43
2016-12-31 $0.03B $0.02B 1.94
2016-09-30 $0.03B $0.02B 1.71
2016-06-30 $0.03B $0.02B 1.57
2016-03-31 $0.03B $0.02B 2.16
2015-12-31 $0.03B $0.02B 2.11
2015-09-30 $0.04B $0.02B 2.29
2015-06-30 $0.03B $0.03B 1.00
2015-03-31 $0.01B $0.01B 1.15
2014-12-31 $0.01B $0.01B 0.64
2014-09-30 $0.01B $0.02B 0.60
2014-06-30 $0.01B $0.01B 0.75
2014-03-31 $0.01B $0.01B 1.73
2013-12-31 $0.01B $0.01B 0.70
2013-09-30 $0.00B $0.01B 0.28
2013-06-30 $0.01B $0.02B 0.52
2013-03-31 $0.01B $0.02B 0.36
2012-12-31 $0.00B $0.01B 0.24
2012-09-30 $0.00B $0.02B 0.15
2012-06-30 $0.00B $0.02B 0.13
2012-03-31 $0.00B $0.02B 0.07
2011-12-31 $0.00B $0.03B 0.05
2011-09-30 $0.00B $0.02B 0.08
2011-06-30 $0.00B $0.02B 0.06
2011-03-31 $0.00B $0.03B 0.07
2010-12-31 $0.00B $0.03B 0.06
2010-09-30 $0.00B $0.04B 0.05
2010-06-30 $0.00B $0.03B 0.07
2010-03-31 $0.00B $0.03B 0.05
2009-12-31 $0.00B $0.03B 0.06
2009-09-30 $0.00B $0.03B 0.06
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.096B 54.00
Hims & Hers Health (HIMS) United States $13.681B 142.14
Tempus AI (TEM) United States $11.156B 0.00
Inspire Medical Systems (INSP) United States $4.596B 71.81
IRhythm Technologies (IRTC) United States $4.484B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.069B 11.53
Schrodinger (SDGR) United States $1.747B 0.00
Clover Health Investments (CLOV) United States $1.691B 0.00
Phreesia (PHR) United States $1.537B 0.00
Omnicell (OMCL) United States $1.346B 23.74
Azenta (AZTA) United States $1.233B 57.32
10x Genomics (TXG) United States $1.115B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.517B 154.50
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.435B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.372B 825.00
Health Catalyst (HCAT) United States $0.291B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
American Well (AMWL) United States $0.111B 0.00
CareCloud (CCLD) United States $0.086B 3.27
MDxHealth SA (MDXH) Belgium $0.084B 0.00
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
Outset Medical (OM) United States $0.067B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00